This is a very enlightening and cautionary thread focused on Chat GPT and its potential in supporting or endangering the HIFA vision.
I am personally blown away by some of the advances in AI and the potential it has in many fields of health care (focusing on the positive) while being cognisant of risks and unintended consequences.
I found this paper in Nature particuarly insightful on the use of large language models in medicine https://www.nature.com/articles/s43856-023-00370-1
The authors “provide a systematic and comprehensive overview of the potentials and limitations of LLMs in clinical practice, medical research and medical education.”
Figure 1 is particularly useful in summarising many of the key issues and we should think about what a similar image might look like for HIFA & LLMs.
The rabbit is out of the hat and we should try and influence what happens next in relation to achieving our vision alongside this technology.
Jules
HIFA profile: Julie has over a decade of experience working for WHO on the development, implementation and evaluation of global improvement programmes in the field of patient safety, quality and infection prevention and control, with a focus on behaviour change. Her current work spans two WHO units – quality Universal Health Coverage and Global Infection Prevention and Control (IPC). Her technical and leadership expertise was called on to support WHO’s Ebola response and recovery efforts in 2014/15, with a focus on national IPC policy development in Sierra Leone. She led on the development of the recently published evidence based WHO Guidelines on the Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. She was previously President of the Infection Prevention Society of the UK and Ireland, Assistant Director at the English National Patient Safety Agency and Director of the seminal cleanyourhands campaign. Julie has authored a book (Perspectives and Perceptions of IPC – highly commended at the 2016 BMA Medical Book Awards), published widely in the academic literature and is peer reviewer of a range of academic journals including Implementation Science, and on the international advisory board of the Journal of Infection Prevention. She is currently studying for a doctorate in public health (health care leadership and management) at Johns Hopkins Bloomberg School of Public Health, Baltimore. https://www.hifa.org/support/members/julie-0 Email: julesstorr AT me.com